TY - JOUR
T1 - Cancer survivorship and risk of pregnancy complications, adverse obstetric outcomes, and maternal morbidities in female adolescents and young adults
T2 - a nationwide population-based study from Taiwan
AU - Kao, Wei Heng
AU - Kuo, Chang Fu
AU - Chang, Chia Chun
AU - Liu, Yu Cheng
AU - Wang, Chun Chieh
AU - Hsu, Jun Te
AU - Chuang, Yi Fang
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2023/8/24
Y1 - 2023/8/24
N2 - Background: Cancer treatment in female adolescent and young adult (AYA) cancer survivors (i.e., those diagnosed between 15 and 39 years of age) may adversely affect multiple bodily functions, including the reproductive system. Methods: We initially assembled a retrospective, nationwide population-based cohort study by linking data from two nationwide Taiwanese data sets. We subsequently identified first pregnancies and singleton births to AYA cancer survivors (2004–2018) and select AYA without a previous cancer diagnosis matched to AYA cancer survivors for maternal age and infant birth year. Results: The study cohort consisted of 5151 and 51,503 births to AYA cancer survivors and matched AYA without a previous cancer diagnosis, respectively. The odds for overall pregnancy complications (odds ratio [OR], 1.09; 95% confidence interval [CI], 1.01–1.18) and overall adverse obstetric outcomes (OR, 1.07; 95% CI, 1.01–1.13) were significantly increased in survivors compared with matched AYA without a previous cancer diagnosis. Specifically, cancer survivorship was associated with an increased risk of preterm labour, labour induction, and threatened abortion or threatened labour requiring hospitalisation. Conclusions: AYA cancer survivors are at increased risk for pregnancy complications and adverse obstetric outcomes. Efforts to integrate individualised care into clinical guidelines for preconception and prenatal care should be thoroughly explored.
AB - Background: Cancer treatment in female adolescent and young adult (AYA) cancer survivors (i.e., those diagnosed between 15 and 39 years of age) may adversely affect multiple bodily functions, including the reproductive system. Methods: We initially assembled a retrospective, nationwide population-based cohort study by linking data from two nationwide Taiwanese data sets. We subsequently identified first pregnancies and singleton births to AYA cancer survivors (2004–2018) and select AYA without a previous cancer diagnosis matched to AYA cancer survivors for maternal age and infant birth year. Results: The study cohort consisted of 5151 and 51,503 births to AYA cancer survivors and matched AYA without a previous cancer diagnosis, respectively. The odds for overall pregnancy complications (odds ratio [OR], 1.09; 95% confidence interval [CI], 1.01–1.18) and overall adverse obstetric outcomes (OR, 1.07; 95% CI, 1.01–1.13) were significantly increased in survivors compared with matched AYA without a previous cancer diagnosis. Specifically, cancer survivorship was associated with an increased risk of preterm labour, labour induction, and threatened abortion or threatened labour requiring hospitalisation. Conclusions: AYA cancer survivors are at increased risk for pregnancy complications and adverse obstetric outcomes. Efforts to integrate individualised care into clinical guidelines for preconception and prenatal care should be thoroughly explored.
UR - http://www.scopus.com/inward/record.url?scp=85163603159&partnerID=8YFLogxK
U2 - 10.1038/s41416-023-02333-8
DO - 10.1038/s41416-023-02333-8
M3 - Article
C2 - 37386137
AN - SCOPUS:85163603159
SN - 0007-0920
VL - 129
SP - 503
EP - 510
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 3
ER -